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Epidural Steroid Injection for
Lumbosacral Radiculopathy
ow back pain combined with radicular pain
remains as one of the most challenging
musculoskeletal problems for its therapeutic
management (1). This malady results from nerve root
impingement and/or inflammation that causes neurologic
symptoms in the distribution of the affected nerve root(s).
Conservative treatment, percutaneous spine interventions
and surgery have all been used as treatments; and the
particular treatment that’s chosen depends on the severity
of the clinical and neurologic presentation. In 1930, Evans
reported that sciatica could be treated by epidural
injection. The use of epidural corticosteroid injections for
the treatment of axial and radicular back pain was first
reported in 1953 (2). Epidural steroid injections are
currently used by many medical professionals for the
treatment of lumbosacral radiculopathy. Performing
“blind” epidural steroid injection lacks target specificity
that often results in incorrect delivery of medication to the
lesion. Imaging-guided steroid injections are now becoming
more popular despite the controversy regarding their
efficacy. Many reports, including a few randomized
controlled trials, have documented the clinical utility of
epidural steroid injections.  
There has been confusion in the literature regarding the
terminology of a ‘proper’ epidural steroid injection (2). The
term transforaminal epidural injection has been incorrectly
referred to as selective epidural injections, selective nerve
root blocks or nerve root sleeve injections. Additionally,
the interlaminar epidural injections have been referred to
the translaminar epidural injections. In our review of the
MEDLINE literature, most of the articles entitled epidural
steroid injection were concerned with the interlaminar
approach. Gajraj (3) recommended that this therapeutic
procedure be referred to a transforaminal epidural
injection and the diagnostic procedure should be referred
to as selective spinal nerve block. The International Spinal
Injection Society (ISIS) recommends the utilization of the
nomenclature based on the precise anatomic descriptors,
i.e., transforaminal and interlaminar for the description of
epidural injections. 
The epidural space has been accessed inferiorly through
the caudal approach or posteriorly through the interlami-
nar approach, and often without employing fluoroscopy.
The transforaminal technique described by Derby et al. (4)
involves positioning of a needle without pain provocation.
Both the interlaminar and caudal epidural injections
require relatively large volumes of the injectants for
delivering steroids to the target site. This has the risk of an
extra-epidural and intravascular needle placement. A
transforaminal epidural steroid injection (TFESI) using a
small volume of local anesthetic will anesthetize the spinal
nerve and also partially anesthetize the dura, the posterior
longitudinal ligament, the intervertebral disc and the facet
joint. For these reasons, fluoroscopy-guided TFESI has
become the preferred approach to the epidural space. 
Some reports have demonstrated the efficacy of TFESI
for the treatment of radiculopathy. When the conventional
TFESI technique is employed, a spinal needle is positioned
within the “safe triangle” with the bevel below the inferior
aspect of the pedicle. A safe triangle is described with the
sides corresponding to the horizontal base of the pedicle,
the exiting nerve root and the posterolateral border of the
vertebral body. In most cases of lumbosacral radiculopathy
that are secondary to spinal stenosis or disc herniation, the
site of impingement can lie at the level of the supra-
adjacent intervertebral disc, which is rostral to the conven-
tional lumbar TFESI bevel position. Lew et al. (5)
suggested that because one cannot always guarantee a
rostral spread of the injectant to bathe the epidural/pregan-
glionic portion of the nerve root, a preganglionic approach
at the level of the supra-adjacent intervertebral disc would
be useful as a supplementary injection technique to the
conventional TFESI. By utilizing the preganglionic
approach to TFESI, the theoretical benefits are placing the
injectant closer to the site of neural impingement to create
a more effective washout of the related inflammatory disc
material. However, their suggestion was not based on a
clinical study. 
The study by Lee et al. (6) in this issue has clinically
assessed the effectiveness of TFESI with using a pregan-
glionic approach for lumbar radiculopathy when the nerve
root compression is located at the level of the supra-
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responses of 13 patients following the conventional TFESI,
and also the responses of 20 patients following the pregan-
glionic TFESI. The conventional group had a success rate
of 69.2% (9/13 patients), whereas the preganglionic group
had a success rate of 90% (18/20). The difference in the
success rates between the two groups was of the borderline
significance with a p value of 0.056. The authors addressed
some limitations to their study, including that it was a
nonrandomized study, it lacked long-term follow-up and
there was the possibility that other factors influenced the
therapeutic outcome. Despite the limitations, they were
able to conclude that the preganglionic TFESI is more
effective in managing radiculopathy than was the conven-
tional TFESI. In that study, there was no statistically signifi-
cant positive impact on the pain reducing benefit from the
preganglionic approach. I believe that this statistically
borderline significance with performing the nonparametric
analysis probably reflects the small sample size when the
preganglionic TFESI was compared to the conventional
TFESI. Future studies may include a larger patient popula-
tion to better evaluate the efficacy of preganglionic TFESI
for the management of radicular pain from herniated disc
and spinal stenosis. 
The main advantage of the preganglionic approach over
the conventional technique is the accurate delivery of
medications to the target site. This requires the use of an
imaging-guided transforaminal access to the side at the
level of the nerve impingement and a preinjection test,
with demonstration of flow of the contrast medium to the
target tissue. This often requires changing the direction of
the needle for correct placement. The authors of the above
study attempted to use a modified approach based on Lew
et als’ technique. They have done a superb job in compar-
ing the two approaches of TFESI. They should be
commended for their efforts in providing the basis for a
future prospective study for the treatment of lumbosacral
radiculopathy. A future, controlled, prospective study
needs to be designed with a consensus opinion on the
effective route of administration, the timing of injection,
the follow-up periods and the outcome measurement with
using both subjective and objective scales. It is hoped that
a prospective, clinical trial with this newer approach will
define the clinical utility and effectiveness of the pregan-
glionic TFESI. 
Is an injection of corticosteroid into the epidural space an
effective means of controlling subjective complaints and
improving objective measures? In the literature, the
efficacy of lumbar epidural injections for radicular pain
lasts for less than 3 months (7). Ridley et al. (8) reported
that the therapeutic benefits disappeared within 6 months
of the treatment. However, Lutz et al. (9) reported the
therapeutic long-term effects (75.4%) of TFESI at an
average follow-up of 20 months. How does epidural
steroid injection compare with the other forms of non-
surgical or surgical management? Several studies have
suggested that TFESI is effective in treating radicular pain.
A randomized trial of TFESI should compare alternative
therapies, including conservative treatment, surgical
decompression or the interlaminar steroid injection
approach. Thomas et al. (10) have reported that TFESI
showed significantly better results on days 6 and 30 and at
6 months as compared with the blindly performed
interlaminar approach. Manchikanti et al. (11) found that
transforaminal injections were the most effective with the
least expense when compared with blind interlaminar
injection and the caudal approach under fluoroscopy.
There is controversy as to the ability of epidural steroid
injection to reduce the need for an operation in the
patients suffering with radicular pain (12). However, a
temporary response to TFESI may predict a favorable
surgical outcome (4).
Epidural steroid injections and selective nerve root
blocks have been used for spinal pain management for
many years. A major criticism of most of the early studies
done on epidural steroid efficacy is their use of “blind”
approaches and therefore, their lack of target specificity.
Even in experienced hands, blind epidural injections result
in incorrect placement of the injectant in up to 30% of the
cases. The newer minimally invasive, imaging guided
percutaneous techniques with fluoroscopy or computed
tomography have recently been added to the list of
available treatment options for spinal pain. Imaging-guided
injections are more likely to place medication at the exact
target, which yields diagnostic feedback and maximizes the
therapeutic effects. Therefore, these newer technique are
gaining popularity despite the controversy regarding their
effectiveness. 
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